𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients

✍ Scribed by Jay S. Schneider; Stephen M. Gollomp; Stephanie Sendek; Amy Colcher; Franca Cambi; Wei Du

Book ID
119304712
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
730 KB
Volume
324
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Double-blind, randomized, controlled tri
Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients
✍ Matthew B. Stern; Kenneth L. Marek; Joseph Friedman; Robert A. Hauser; Peter A. πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 172 KB πŸ‘ 2 views

## Abstract Rasagiline (__N__‐propargyl‐1(__R__)‐aminoindan) mesylate is a potent, selective, and irreversible monoamine oxidase‐B inhibitor. This study was designed to evaluate the safety, tolerability, and preliminary efficacy of rasagiline monotherapy in early Parkinson's disease (PD) patients n

A pilot randomized controlled trial of s
A pilot randomized controlled trial of sleep therapy in Parkinson's disease: effect on patients and caregivers
✍ Iracema Leroi; Peter Baker; Pam Kehoe; Emily Daniel; E Jane Byrne πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 128 KB πŸ‘ 2 views

## Abstract ## Objective By means of a controlled trial, to investigate the efficacy, tolerability and feasibility of a multi‐component sleep therapy intervention versus basic sleep hygiene education in PD patients with sleep disturbances and their live‐in carers. ## Methods Patient‐carer dyads